Coland Holdings Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Coland Holdings Limited with three other
companies in this sector in China:
Chongqing Pharscin Pharmaceutical Co LtdChongqing Pharscin Pharmaceutical Co L td
sales of 592.10 million Chinese Renmimbi [US$86.55 million]
of which 82%
was Medicine Industry),
Lansen Pharmaceutical Holdings Limited
(602.67 million Chinese Renmimbi [US$88.10 million]
of which 76%
was Specialty Pharmaceuticals), and
Chengdu Taihe Health Technology Group Inc Ltd
(590.95 million Chinese Renmimbi [US$86.38 million]
of which 86%
was Medicine Manufacturing).
Coland Holdings Limited reported sales of 586.59 million Chinese Renmimbi (US$85.75 million)
December of 2017.
decrease of 13.1%
versus 2016, when the company's sales were 675.24 million Chinese Renmimbi.